⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 9, 2024Neurology

Compound Muscle Action Potential (CMAP) Duration and Myosin Loss in Patients with Critical Illness Myopathy: Correlation and Prognostication (P1-11.005)

Shahar Shelly Pannathat Soontrapa Nicolas N. Madigan Michael J. Polzin Tarun D. Singh Sri Raghav Sista Pritikanta Paul Bing Liao Sherri A. Braksick Andrea J. Boon William J. Litchy Margherita Milone Teerin Liewluck

View Full Paper

Ask AI

Bookmark

Share

Abstract

To study the correlation between compound muscle action potential (CMAP) duration and myosin loss and their prognostic values in critical illness myopathy (CIM).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Shelly et al. (2024) studied this question.

synapsesocial.com/papers/68e6fdadb6db643587677d23 https://doi.org/10.1212/wnl.0000000000205833

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Compound Muscle Action Potential and Myosin-Loss Pathology in Patients With Critical Illness Myopathy2024 · 3 citations
2New Measurement in the Diagnosis of Critical Illness Myopathy: Stimulus Intensity and Compound Muscle Action Potential Duration Relationship (P1-11.013)2024
3Critical Illness Myopathy: Diagnostic Approach and Resulting Therapeutic Implicationsreview · 2022 · 21 citations
4Myosin Post-translational Modifications Associated with Critical Illness Myopathy2025 · 1 citations
5Serial Compound Muscle Action Potential to Assess Improvement Following Gene Modifying and Replacement Therapies in Spinal Muscular Atrophy (P5-9.007)cohort · 2026